Document is current
Any future updates will be listed below
-
Authors
Miller, Kevin C.
Chintakuntlawar, Ashish V.
- License Information
-
More Information
Article History
Accepted: 11 January 2021
First Online: 10 February 2021
Declarations
:
: Kevin C. Miller declares that he has no conflict of interest. Ashish V. Chintakuntlawar has received clinical trial funding (paid to his institution) from Merck, AstraZeneca/MedImmune, Kura Oncology, Inovio Pharmaceuticals, and Eisai, and has served on advisory boards for Kura Oncology and HRA Pharma (both institutional).
